Review



rabbit anti human lilrb4 antibody  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 92

    Structured Review

    Proteintech rabbit anti human lilrb4 antibody
    (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in <t>LILRB4</t> expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.
    Rabbit Anti Human Lilrb4 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 5 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+lilrb4/LILRB4+Antibody/pmc12716741-83-24-23
    Average 92 stars, based on 5 article reviews
    rabbit anti human lilrb4 antibody - by Bioz Stars, 2026-09
    92/100 stars

    Images

    1) Product Images from "The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells"

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells

    Journal: PLOS One

    doi: 10.1371/journal.pone.0339375

    (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in LILRB4 expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.
    Figure Legend Snippet: (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in LILRB4 expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.

    Techniques Used: Gene Expression, Expressing, Western Blot, Flow Cytometry

    (A) Schematic representation of the BiKE structure. (B) Schematic representation of BiKE-mediated NK cells killing of tumors. (C) BiKE SDS-PAGE of non-reduced and reduced proteins, stained with Coomassie blue. (D) ELISA test measuring the affinity of different concentrations of BiKE to the LILRB4 antigen. (E) Elisa tests the affinity of different concentrations of BiKE to the CD16A antigen. (F) Indirect labeling Flow cytometry was used to assess the binding ability of BiKE to MM1.S, NK, and K562 cells. Goat anti human IgG (H + L) antibody labeled with FITC as the secondary antibody. (G) PBMCs were co-cultured with LILRB4 + MM1.S cells for 4 hours. The regulation of CD69 expression in NK cells by monoclonal antibodies and BiKE in the co-culture system was analyzed by flow cytometry. Data are presented as mean ± SD, *P < 0.05, ***P < 0.001, ****P < 0.0001, n = 4 compared to each other group by one-way ANOVA.
    Figure Legend Snippet: (A) Schematic representation of the BiKE structure. (B) Schematic representation of BiKE-mediated NK cells killing of tumors. (C) BiKE SDS-PAGE of non-reduced and reduced proteins, stained with Coomassie blue. (D) ELISA test measuring the affinity of different concentrations of BiKE to the LILRB4 antigen. (E) Elisa tests the affinity of different concentrations of BiKE to the CD16A antigen. (F) Indirect labeling Flow cytometry was used to assess the binding ability of BiKE to MM1.S, NK, and K562 cells. Goat anti human IgG (H + L) antibody labeled with FITC as the secondary antibody. (G) PBMCs were co-cultured with LILRB4 + MM1.S cells for 4 hours. The regulation of CD69 expression in NK cells by monoclonal antibodies and BiKE in the co-culture system was analyzed by flow cytometry. Data are presented as mean ± SD, *P < 0.05, ***P < 0.001, ****P < 0.0001, n = 4 compared to each other group by one-way ANOVA.

    Techniques Used: SDS Page, Staining, Enzyme-linked Immunosorbent Assay, Labeling, Flow Cytometry, Binding Assay, Cell Culture, Expressing, Bioprocessing, Co-Culture Assay

    Related Articles

    Labeling:

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells
    Article Snippet: Briefly, BiKE and the control monoclonal antibody (20 μg/ml) were incubated with cells for 1 hour at room temperature, washed twice with PBS, and incubated with FITC-labeled goat anti-human IgG (H + L) secondary antibody (1:1000, Cat: SA00003−12, Proteintech, China) for 20 minutes at room temperature. .. Additionally, the same indirect labeling method was used to detect LILRB4 expression on MM cell membranes by flow cytometry, using rabbit anti-human LILRB4 (1:1000, Cat: 28422–1-AP, Proteintech, China) as the primary antibody, followed by FITC-labeled goat anti-rabbit IgG (H + L) secondary antibody (1:1000, Cat: SA00003−1, Proteintech, China). .. Cells were then washed twice with PBS and analyzed using Novocyte flow cytometry.

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS-STING agonists enhances the anti-multiple myeloma immune activity of NK cells.
    Article Snippet: Briefly, BiKE and the control monoclonal antibody (20 μg/ml) were incubated with cells for 1 hour at room temperature, washed twice with PBS, and incubated with FITC-labeled goat anti-human IgG (H + L) secondary antibody (1:1000, Cat: SA00003−12, Proteintech, China) for 20 minutes at room temperature. .. Additionally, the same indirect labeling method was used to detect LILRB4 expression on MM cell membranes by flow cytometry, using rabbit anti-human LILRB4 (1:1000, Cat: 28422–1-AP, Proteintech, China) as the primary antibody, followed by FITC-labeled goat anti-rabbit IgG (H + L) secondary antibody (1:1000, Cat: SA00003−1, Proteintech, China). .. Cells were then washed twice with PBS and analyzed using Novocyte flow cytometry.

    Expressing:

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells
    Article Snippet: Briefly, BiKE and the control monoclonal antibody (20 μg/ml) were incubated with cells for 1 hour at room temperature, washed twice with PBS, and incubated with FITC-labeled goat anti-human IgG (H + L) secondary antibody (1:1000, Cat: SA00003−12, Proteintech, China) for 20 minutes at room temperature. .. Additionally, the same indirect labeling method was used to detect LILRB4 expression on MM cell membranes by flow cytometry, using rabbit anti-human LILRB4 (1:1000, Cat: 28422–1-AP, Proteintech, China) as the primary antibody, followed by FITC-labeled goat anti-rabbit IgG (H + L) secondary antibody (1:1000, Cat: SA00003−1, Proteintech, China). .. Cells were then washed twice with PBS and analyzed using Novocyte flow cytometry.

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS-STING agonists enhances the anti-multiple myeloma immune activity of NK cells.
    Article Snippet: Briefly, BiKE and the control monoclonal antibody (20 μg/ml) were incubated with cells for 1 hour at room temperature, washed twice with PBS, and incubated with FITC-labeled goat anti-human IgG (H + L) secondary antibody (1:1000, Cat: SA00003−12, Proteintech, China) for 20 minutes at room temperature. .. Additionally, the same indirect labeling method was used to detect LILRB4 expression on MM cell membranes by flow cytometry, using rabbit anti-human LILRB4 (1:1000, Cat: 28422–1-AP, Proteintech, China) as the primary antibody, followed by FITC-labeled goat anti-rabbit IgG (H + L) secondary antibody (1:1000, Cat: SA00003−1, Proteintech, China). .. Cells were then washed twice with PBS and analyzed using Novocyte flow cytometry.

    Flow Cytometry:

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells
    Article Snippet: Briefly, BiKE and the control monoclonal antibody (20 μg/ml) were incubated with cells for 1 hour at room temperature, washed twice with PBS, and incubated with FITC-labeled goat anti-human IgG (H + L) secondary antibody (1:1000, Cat: SA00003−12, Proteintech, China) for 20 minutes at room temperature. .. Additionally, the same indirect labeling method was used to detect LILRB4 expression on MM cell membranes by flow cytometry, using rabbit anti-human LILRB4 (1:1000, Cat: 28422–1-AP, Proteintech, China) as the primary antibody, followed by FITC-labeled goat anti-rabbit IgG (H + L) secondary antibody (1:1000, Cat: SA00003−1, Proteintech, China). .. Cells were then washed twice with PBS and analyzed using Novocyte flow cytometry.

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS-STING agonists enhances the anti-multiple myeloma immune activity of NK cells.
    Article Snippet: Briefly, BiKE and the control monoclonal antibody (20 μg/ml) were incubated with cells for 1 hour at room temperature, washed twice with PBS, and incubated with FITC-labeled goat anti-human IgG (H + L) secondary antibody (1:1000, Cat: SA00003−12, Proteintech, China) for 20 minutes at room temperature. .. Additionally, the same indirect labeling method was used to detect LILRB4 expression on MM cell membranes by flow cytometry, using rabbit anti-human LILRB4 (1:1000, Cat: 28422–1-AP, Proteintech, China) as the primary antibody, followed by FITC-labeled goat anti-rabbit IgG (H + L) secondary antibody (1:1000, Cat: SA00003−1, Proteintech, China). .. Cells were then washed twice with PBS and analyzed using Novocyte flow cytometry.



    Similar Products

    92
    Proteintech rabbit anti human lilrb4 antibody
    (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in <t>LILRB4</t> expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.
    Rabbit Anti Human Lilrb4 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+lilrb4/LILRB4+Antibody/pmc12716741-83-24-23
    Average 92 stars, based on 1 article reviews
    rabbit anti human lilrb4 antibody - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    92
    Proteintech rabbit anti human lilrb4
    (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in <t>LILRB4</t> expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.
    Rabbit Anti Human Lilrb4, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+lilrb4/LILRB4+Antibody/pm41417876-108-20-26
    Average 92 stars, based on 1 article reviews
    rabbit anti human lilrb4 - by Bioz Stars, 2026-09
    92/100 stars
      Buy from Supplier

    90
    Signalway Antibody rabbit anti-human lilrb4 igg antibody #55107
    Prognostic value of LYZ and <t>LILRB4</t> proteins in DLBCL receiving R-CHOP ( n = 37, 10X) and aNSCLC receiving ICIs ( n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1 + macrophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival
    Rabbit Anti Human Lilrb4 Igg Antibody #55107, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+anti+human+lilrb4/rabbit+anti+human+lilrb4+igg+antibody++55107/pmc11861843-39-0-8
    Average 90 stars, based on 1 article reviews
    rabbit anti-human lilrb4 igg antibody #55107 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in LILRB4 expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.

    Journal: PLOS One

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells

    doi: 10.1371/journal.pone.0339375

    Figure Lengend Snippet: (A) Uniform manifold approximation and projection (UMAP) dimensionality reduction clustering identifies multiple cell subpopulations of multiple myeloma cells. (B) The Volcano plots display the gene expression profiles of each tumor cell subpopulation with significant differences compared to other subpopulations. Log2 (fold change) > 1 and adjusted P < 0.05 were considered as significantly differentially expressed genes. (C) Heatmap showing precise differences in LILRB4 expression across tumor cell subsets. (D) Density plot of LILRB4 expression in tumor cells from UMAP. Color intensity indicates the expression level. (E) Copy Number Variation Score for Tumor Subpopulation Cells. (F) Metabolic pathway enrichment analysis of differentially expressed genes in tumor cell subsets, where color intensity reflects the degree of correlation. (G) Dotplot diagrams display the expression of ligand–receptor pairs between LILRB4 + MM cells (the initiating point of communication) and other cells. (H) LILRB4-related survival analysis in MM was performed using the TCGA database, with P values calculated by the log-rank test. (I) Western blot analysis was used to detect LILRB4 protein expression levels in MM1.S and RPMI-8226 cells. (J) Flow cytometry was employed to assess the expression of LILRB4 protein in MM1.S and RPMI-8226 cells.

    Article Snippet: The membranes were blocked with 5% nonfat dry milk for 2 hours, incubated overnight at 4°C with primary antibodies (1:1000 dilution, rabbit anti-human, Proteintech), Rabbit anti-human LILRB4 antibody was used to detect the expression of LILRB4 in MM cell lines, which used GAPDH as an internal reference.

    Techniques: Gene Expression, Expressing, Western Blot, Flow Cytometry

    (A) Schematic representation of the BiKE structure. (B) Schematic representation of BiKE-mediated NK cells killing of tumors. (C) BiKE SDS-PAGE of non-reduced and reduced proteins, stained with Coomassie blue. (D) ELISA test measuring the affinity of different concentrations of BiKE to the LILRB4 antigen. (E) Elisa tests the affinity of different concentrations of BiKE to the CD16A antigen. (F) Indirect labeling Flow cytometry was used to assess the binding ability of BiKE to MM1.S, NK, and K562 cells. Goat anti human IgG (H + L) antibody labeled with FITC as the secondary antibody. (G) PBMCs were co-cultured with LILRB4 + MM1.S cells for 4 hours. The regulation of CD69 expression in NK cells by monoclonal antibodies and BiKE in the co-culture system was analyzed by flow cytometry. Data are presented as mean ± SD, *P < 0.05, ***P < 0.001, ****P < 0.0001, n = 4 compared to each other group by one-way ANOVA.

    Journal: PLOS One

    Article Title: The combination of LILRB4-targeting NK cell engagers and cGAS–STING agonists enhances the anti–multiple myeloma immune activity of NK cells

    doi: 10.1371/journal.pone.0339375

    Figure Lengend Snippet: (A) Schematic representation of the BiKE structure. (B) Schematic representation of BiKE-mediated NK cells killing of tumors. (C) BiKE SDS-PAGE of non-reduced and reduced proteins, stained with Coomassie blue. (D) ELISA test measuring the affinity of different concentrations of BiKE to the LILRB4 antigen. (E) Elisa tests the affinity of different concentrations of BiKE to the CD16A antigen. (F) Indirect labeling Flow cytometry was used to assess the binding ability of BiKE to MM1.S, NK, and K562 cells. Goat anti human IgG (H + L) antibody labeled with FITC as the secondary antibody. (G) PBMCs were co-cultured with LILRB4 + MM1.S cells for 4 hours. The regulation of CD69 expression in NK cells by monoclonal antibodies and BiKE in the co-culture system was analyzed by flow cytometry. Data are presented as mean ± SD, *P < 0.05, ***P < 0.001, ****P < 0.0001, n = 4 compared to each other group by one-way ANOVA.

    Article Snippet: The membranes were blocked with 5% nonfat dry milk for 2 hours, incubated overnight at 4°C with primary antibodies (1:1000 dilution, rabbit anti-human, Proteintech), Rabbit anti-human LILRB4 antibody was used to detect the expression of LILRB4 in MM cell lines, which used GAPDH as an internal reference.

    Techniques: SDS Page, Staining, Enzyme-linked Immunosorbent Assay, Labeling, Flow Cytometry, Binding Assay, Cell Culture, Expressing, Bioprocessing, Co-Culture Assay

    Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP ( n = 37, 10X) and aNSCLC receiving ICIs ( n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1 + macrophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Prognostic value of LYZ and LILRB4 proteins in DLBCL receiving R-CHOP ( n = 37, 10X) and aNSCLC receiving ICIs ( n = 29, 2X and 10X). A Representative IHCs staining of LYZ in patient 1 (PFS = 1697 days) and patient 2 (PFS = 341 days), LILRB4 in patient 3 (PFS = 64 days) and patient 4 (PFS = 826 days). B Kaplan–Meier survival curves of PFS grouped by the LYZ and LILRB4 expression in DLBCL. C Representative mIF staining of LYZ, LILRB4, and pan Cytokeratin. D Kaplan–Meier survival curves of OS grouped by the LYZ and LILRB4 expression in aNSCLC. E Kaplan–Meier survival curves of PFS grouped by the COL3A1 expression and FN1 + macrophages in DLBCL. DLBCL: diffuse large B cell lymphoma; R-CHOP: rituximab, cyclophosphamide, doxorubicin: vincristine, and prednisone; aNSCLC: advanced non-small cell lung cancer; ICIs: immune checkpoint inhibitors; IHC: immunohistochemistry; PFS: progression-free survival; mIF: multiple immunofluorescence; and OS: overall survival

    Article Snippet: Rabbit anti-human LILRB4 IgG antibody , #55107 , Signalway antibody.

    Techniques: Staining, Expressing, Immunohistochemistry, Immunofluorescence

    Reagents and tools table

    Journal: Cancer Immunology, Immunotherapy : CII

    Article Title: Spatial transcriptomics reveals prognostically LYZ + fibroblasts and colocalization with FN1 + macrophages in diffuse large B-cell lymphoma

    doi: 10.1007/s00262-025-03968-7

    Figure Lengend Snippet: Reagents and tools table

    Article Snippet: Rabbit anti-human LILRB4 IgG antibody , #55107 , Signalway antibody.

    Techniques: Formalin-fixed Paraffin-Embedded, Gene Expression, RNA Sequencing, Sequencing, Biomarker Discovery, Clinical Proteomics, Microarray, Control, Immunohistochemistry, Microscopy, Immunofluorescence, Software